| abstract |
IT REFERS TO A PROCEDURE FOR PREPARING A COMPOUND OF FORMULA I, WHERE R1 AND R2 ARE EACH C1-C12 ALKYL, HETEROARYL, ARYL, AMONG OTHERS; R3 IS H, C1-C6 ALKYL, C3-C7 CYCLOALKYL, ARYL, HETEROARYL, CN, AMONG OTHERS, WHICH INCLUDES IN REACTING VI WITH A REDUCING AGENT SELECTED FROM ALUMINUM HYDRIDE LITHIUM OR SODIUM METHYL BIS (2-METHIUM BIS) ALUMINUM, WHERE R4 IS H, ALCOXY C1-C6. THROUGH SAID PROCEDURE, IT IS OBTAINED: [4- (2-HEXAMETHYLENIMIN-1-IL-ETOXY) -PHENYL] -METHANOL; 4- (2-OXO-HEXAMETHYLENIMINE-ETOXY) -BENZALDEHYDE; AMONG OTHERS. IT ALSO REFERS TO THE PREPARATION OF INTERMEDIARIES, SAID PROCEDURE REDUCES COSTS AND PROVIDES ADVANTAGES FOR THE PREPARATION OF FOR EXAMPLE METALOPROTEINASE INHIBITORS FROM THE MATRIX AND ENZYME CONVERTASA OF TNF-ALPHA TREATMENT METHERISTRY, UTILITY TREATMENT, METALLIC TREATMENT, UTILITY TREATY , PERIODONTAL DISEASE, AMONG OTHERS |